Natalie Cook

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Michael A. Jacobetz, Derek Chan, Tashinga E. Bapiro et al. · Gut · 2012 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Hugo Ford, Andrea Marshall, John Bridgewater et al. · The Lancet Oncology · 2013 · 604 citations · Full text

Public Health, Community Health, Communities Of Practice +14

<i>nab</i> -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer

Kristopher K. Frese, Natalie Cook, Tashinga E. Bapiro et al. · Cancer Discovery · 2012 · 425 citations · Full text

Medicine, Oncology, Pharmacology +14

Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study

Dominic G. Rothwell, Mahmood Ayub, Natalie Cook et al. · Nature Medicine · 2019 · 306 citations · Full text

Medicine, Oncology, Radiology +10

First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

Gerald S. Falchook, Jeffrey R. Infante, Hendrik‐Tobias Arkenau et al. · EClinicalMedicine · 2021 · 275 citations · Full text

Medicine, Oncology, Pharmacology +14